Real world study comparing commonly prescribed COPD medicines shows choice of treatment has impact on patient outcomes

[at noodls] – AstraZeneca today announced that an analysis of data from real world study PATHOS, published in the Journal of Internal Medicine, show that chronic obstructive pulmonary disease (COPD) patients treated … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view